###### Strengths and limitations of this study

-   This study confirms that ethnicity influences the association between anthropometric obesity measures and cardiovascular disease (CVD) risk.

-   Central obesity measures such as waist circumference and waist-to-hip ratio are better indicators of CVD risk compared to body mass index across ethnic groups.

-   The treatment threshold used for a risk score model affects the predictive ability of anthropometric obesity measures and the same cut point may not be suitable across ethnic groups.

-   It is a cross-sectional study of the Australian female population in 1989 and these results require confirmation from prospective studies.

-   Owing to a sample size of about 200 for the Asian population, different regions in Asia could not be compared.

-   The CVD risk was estimated using risk score models in order to stratify individuals above and below the respective treatment thresholds and not actual CVD events.

Introduction {#s1}
============

In Australia, approximately 63% of adults were overweight and obese in 2011--2012.[@R1] The proportion of the Australian population who are overweight and obese is expected to increase to approximately 66% in the next 5 years.[@R2] The National Health and Medical Research Council has developed Clinical Practice Guidelines for the Management of Overweight and Obesity for Adults, Adolescents and Children in Australia to provide guidance on assessing and managing obesity.[@R3]

Overweight and obesity affects all socioeconomic groups in Australia, but it is more prevalent in some ethnic groups.[@R4] [@R5] Variations exist in the associations between excess weight and obesity-related conditions among different racial and ethnic groups. Ethnicity significantly affects the associations between anthropometric indices used to assess adiposity such as body mass index (BMI) and waist circumference (WC) and cardiovascular disease (CVD) risk factors.[@R6]

Previous epidemiological studies which assessed the associations between anthropometric indices of obesity and CVD were mostly conducted in Western societies.[@R7] It is thus not clear which anthropometric obesity measures are more strongly associated with CVD risk in different ethnic groups.[@R8] To address this, it is necessary to examine the relationship between anthropometric obesity measures and CVD risk by ethnicity and this has been proposed in previous studies as well.[@R9] These fundamental issues need to be addressed in order to recommend effective weight management and disease prevention strategies to reduce the burden associated with overweight and obesity in all population groups.

The objectives of this study were to determine whether the cross-sectional associations between anthropometric obesity measures (BMI, WC and waist-to-hip ratio (WHR)) and calculated 10-year CVD risk using the Framingham and general CVD risk score models are the same for women of Australian, UK and Ireland, North European, South European and Asian descent. This study would investigate which anthropometric obesity measure is most predictive at identifying women at increased CVD risk in each ethnic group.

Methods {#s2}
=======

Study participants {#s2a}
------------------

Participants were selected from the third Risk Factor Prevalence Study[@R12] conducted by the National Heart Foundation (NHF) of Australia in 1989. Residents on the federal electoral rolls of December 1988 in North and South Sydney, Melbourne, Brisbane, Adelaide, Perth, Hobart, Darwin and Canberra were recruited for the Risk Factor Prevalence Study by systemic probability sampling of sex and 5-year age groups. Complete data were available on 4727 women. Country of birth was used as a surrogate for ethnicity and grouped into regions.[@R12] Most participants were of Australian, UK and Ireland, North European, South European or Asian descent (97%). We selected a representative sample of 4354 women aged 20--69 years with no history of heart disease, diabetes or stroke for analysis. There were 3329 Australian women, 416 women from the UK and Ireland, 180 Northern European women, 234 Southern European women and 195 Asian women. Further details have been described in the third Risk Factor Prevalence Study and in a previous study.[@R12] [@R13]

Ethics statement {#s2b}
----------------

Participation was entirely voluntary. Those who participated signed an informed consent form.[@R12] Participant information was anonymised prior to analysis.

Anthropometry {#s2c}
-------------

A single record of height (to the nearest centimetre) and weight (to the nearest 10th of a kilogram) was taken in light summer clothes without shoes. BMI was calculated based on weight in kilograms divided by square of height in metres. Waist and hip circumferences were measured according to standardised methodologies by trained anthropometrists.[@R14] [@R15] The WC was measured from the front at the narrowest point between the rib cage and iliac crest after full expiration while the hip circumference (HC) was measured from the side at the maximal extension of buttocks by one observer using a metal tape. A second observer recorded another set of measurements and ensured that the metal tape was kept strictly horizontal at all times. The mean of two measurements was taken at each site to the nearest centimetre. The WHR was calculated based on WC divided by the HC. Information on demographic characteristics, medical conditions and smoking behaviour were collected. Mercury sphygmomanometers were used to record blood pressure levels on the right arm of seated participants 5 min apart.[@R12] Two readings were taken and the average was used in the analysis. Fasting blood samples were collected in ethylene diamine tetraacetic acid tubes and despatched to the central laboratory at the Division of Clinical Chemistry, Institute of Medical and Veterinary Science, Adelaide each week for cholesterol levels to be assayed.

Risk score models {#s2d}
-----------------

The Framingham risk score model[@R16] predicts the 10-year CVD incidence. It was developed from the American Framingham Heart Study using participants aged 30--74 years who were free of CVD and cancer. Risk variables used to calculate the 10-year risk include: age, sex, systolic blood pressure (SBP), diastolic blood pressure, total cholesterol level, high-density lipoprotein (HDL) cholesterol level, smoking status, diabetes status and ECG-left ventricular hypertrophy (ECG-LVH).[@R16] The most commonly used treatment threshold for the Framingham model was 20%[@R17]; this denotes that an individual who has a risk score of more than 20% is considered to be at increased risk of experiencing a CVD event within the next 10 years and should be targeted for treatment.

Although the general CVD risk score model for predicting the 10-year CVD incidence and death was also developed based on data from the American Framingham Heart Study, it was developed from a larger cohort and consisted of participants without CVD only.[@R18] The general CVD risk score model contains these variables: age, total cholesterol level, HDL cholesterol level, SBP, current antihypertensive treatment, smoking status and diabetes status.[@R18] Treatment thresholds of 10% and 20% were reported for this model.[@R18] [@R19]

Statistical analysis {#s2e}
--------------------

Demographic and clinical characteristics of the sample were described using mean±SD for continuous variables, while counts (percentages) were used for categorical variables. Comparisons between means of continuous variables were conducted using Analysis of Variance, with age as a covariate and with Bonferroni adjustment for multiple comparisons. Means with different superscripts were significantly different at the 5% level of significance. Non-parametric Spearman\'s rank correlation was used to assess the associations between BMI, WC and WHR and the 10-year predicted CVD risk calculated using Framingham and general CVD risk score models by ethnicity, due to the skewness in the distribution of risk variables. These measures were also converted to z-scores (original value subtracted by the mean and the result divided by the SD) to represent the number of SDs above and below the mean of each anthropometric obesity measure for each individual. Logistic regression was used to assess the effects of each standardised obesity measure of being above the recommended treatment threshold for the respective risk score models (10 and 20%), as a result of a 1 SD increment above the mean of each measure of obesity, by ethnicity. These effects were represented using ORs and associated 95% CIs. The predictive ability of these anthropometric obesity measures to identify individuals from different ethnic groups above the treatment threshold of 20% for the Framingham model for 10-year CVD incidence, and 10 and 20% for the general CVD risk score model for 10-year CVD incidence and death was assessed using the area under the receiver operating characteristic (ROC) curve. Ethnic-specific cut-off values of the anthropometric obesity measures and associated level of specificity to predict increased risk of CVD at 70% and 80% sensitivity were also presented. p Values of less than 0.05 were considered to be statistically significant. All statistical analyses were performed with IBM SPSS Statistics V.21.

Results {#s3}
=======

The demographic and clinical characteristics of the multiethnic sample of 4354 women without heart disease, diabetes or stroke are presented in [table 1](#BMJOPEN2013004702TB1){ref-type="table"}. Southern European women generally had higher BMI, WC and WHR compared to other ethnic groups, and Asian women had lower anthropometric obesity measures.

###### 

Characteristics of the sample of 4354 women without heart disease, diabetes or stroke by ethnicity

                         Statistics   Australia      UK and Ireland   Northern Europe   Southern Europe   Asia
  ---------------------- ------------ -------------- ---------------- ----------------- ----------------- ----------------
  Count                  N            3329           416              180               234               195
  Age (years)            Mean±SD      41.9±13.5      45.7±12.5        49.0±11.7         47.8±10.6         40.5±10.9
  Current smoker (Yes)   n (%)        751 (22.6)     91 (21.9)        39 (21.7)         32 (13.7)         19 (9.7)
  Weight (kg)            Mean±SD      65.4±12.6^a^   65.2±12.0^a^     66.5±12.6^a^      66.9±11.8^a^      58.6±11.6^b^
  Height (cm)            Mean±SD      162.8±6.0^a^   162.3±6.2^a^     161.9±6.2^a^      156.8±6.1^b^      156.7±5.7^b^
  BMI (kg/m^2^)          Mean±SD      24.7±4.8^b^    24.7±4.2^b,c^    25.4±4.6^b,d^     27.2±4.4^a^       23.8±4.3^c,d^
  WC (cm)                Mean±SD      75.9±11.0^b^   76.2±10.5^b^     78.4±11.9^b^      81.2±11.0^a^      73.9±10.4^b^
  WHR                    Mean±SD      0.76±0.06^c^   0.76±0.06^c^     0.77±0.07^b,c^    0.79±0.06^a^      0.77±0.06^a,b^
  SBP (mm Hg)            Mean±SD      122±18^a^      123±18^b,c^      126±19^a,b,c^     127±19^a,b^       116±19^c^
  HDL (mmol/L)           Mean±SD      1.5±0.4^a^     1.5±0.4^a^       1.5±0.4^a^        1.4±0.3^b^        1.4±0.4^a,b^
  TC (mmol/L)            Mean±SD      5.4±1.1        5.6±1.2          5.7±1.3           5.7±1.1           5.2±1.0
  Ratio: HDL to TC       Mean±SD      3.9±1.3^b^     4.0±1.4^a,b^     4.0±1.4^b^        4.3±1.4^a^        3.9±1.2^a,b^

^a,b,c,d^ Means with different superscripts were significantly different at the 5% level of significance, after adjusting for age.

BMI, body mass index; HDL, high-density lipoprotein cholesterol; SBP, systolic blood pressure; TC, total cholesterol; WC, waist circumference; WHR, waist-to-hip ratio.

All Spearman\'s rank correlations were statistically significant (p\<0.0005). Overall, WC appeared to have a stronger association with the 10-year predicted risk calculated using the general CVD and Framingham risk score models across all ethnic groups except in European women ([table 2](#BMJOPEN2013004702TB2){ref-type="table"}). BMI appeared to be more associated with CVD risk calculated using both models in Northern European women, while WHR was more associated with the predicted risk in Southern European women.

###### 

Non-parametric correlations between anthropometric measurements of general and central obesity and 10-year predicted risk of CVD incidence and mortality by ethnicity in 4354 women

  Ethnicity                                                          BMI     WC      WHR
  ------------------------------------------------------------------ ------- ------- -------
  *General CVD 10-year predicted risk for CVD incidence and death*                   
  Australia                                                          0.372   0.443   0.402
  UK and Ireland                                                     0.360   0.406   0.365
  Northern Europe                                                    0.504   0.462   0.435
  Southern Europe                                                    0.356   0.479   0.485
  Asia                                                               0.306   0.396   0.308
  Overall                                                            0.384   0.451   0.408
  *Framingham 10-year predicted risk for CVD incidence*                              
  Australia                                                          0.366   0.440   0.405
  UK and Ireland                                                     0.349   0.399   0.361
  Northern Europe                                                    0.500   0.464   0.445
  Southern Europe                                                    0.358   0.483   0.491
  Asia                                                               0.311   0.402   0.308
  Overall                                                            0.380   0.449   0.412

All Spearman\'s rank correlations significant at the p\<0.0005 level.

BMI, body mass index; WC, waist circumference; WHR, waist-to-hip ratio.

The recommended treatment thresholds for the general CVD risk score model at 10% and 20%, and the Framingham risk score model at 20%, were identified from a review of the literature. [Table 3](#BMJOPEN2013004702TB3){ref-type="table"} presents the effects of a 1 SD increment in BMI, WC and WHR above the mean on the likelihood of being above the recommended threshold in each ethnic group. Increase in anthropometric measurements was generally associated with an increased likelihood of being above the treatment thresholds for all models. A 1 SD change in all obesity measures in Asian women did not have a significant effect on the CVD risk as calculated using the general CVD model both at the 10% and 20% threshold. BMI was not effective in predicting the likelihood of being above the treatment threshold across all models for Southern European women.

###### 

ORs and associated 95% CIs of being above the recommended treatment threshold for various risk score models as a result of a 1 SD increment above the mean for each anthropometric measure of obesity by ethnicity

  Ethnicity                                                                                         BMI                         WC                          WHR
  ------------------------------------------------------------------------------------------------- --------------------------- --------------------------- ---------------------------
  *General CVD 10-year predicted risk for CVD incidence and death (threshold*=*10%)*[@R19]                                                                  
  Australia                                                                                         1.69\*\*\* (1.55 to 1.85)   2.16\*\*\* (1.96 to 2.38)   2.36\*\*\* (2.13 to 2.62)
  UK and Ireland                                                                                    1.71\*\*\* (1.29 to 2.25)   1.86\*\*\* (1.42 to 2.43)   2.09\*\*\* (1.58 to 2.75)
  Northern Europe                                                                                   2.50\*\*\* (1.67 to 3.74)   2.28\*\*\* (1.61 to 3.24)   2.23\*\*\* (1.55 to 3.21)
  Southern Europe                                                                                   1.37 (0.97 to 1.94)         1.64\*\* (1.18 to 2.28)     1.89\*\* (1.32 to 2.70)
  Asia                                                                                              1.14 (0.62 to 2.09)         1.57 (0.97 to 2.56)         1.48 (0.88 to 2.47)
  *General CVD 10-year predicted risk for CVD incidence and death (threshold*=*20%)*[@R18] [@R20]                                                           
  Australia                                                                                         1.65\*\*\* (1.43 to 1.91)   2.07\*\*\* (1.78 to 2.41)   2.11\*\*\* (1.80 to 2.47)
  UK and Ireland                                                                                    1.12 (0.64 to 1.96)         1.22 (0.73 to 2.05)         1.68\* (1.05 to 2.69)
  Northern Europe                                                                                   2.60\*\* (1.44 to 4.70)     2.76\*\*\* (1.58 to 4.80)   3.23\*\*\* (1.74 to 5.97)
  Southern Europe                                                                                   1.17 (0.58 to 2.35)         1.77 (0.96 to 3.28)         2.15\* (1.11 to 4.18)
  Asia                                                                                              0.96 (0.19 to 4.94)         1.15 (0.29 to 4.57)         0.71 (0.13 to 3.92)
  *Framingham 10-year predicted risk for CVD incidence (threshold*=*20%)*[@R21] [@R22]                                                                      
  Australia                                                                                         1.67\*\*\* (1.52 to 1.82)   2.13\*\*\* (1.94 to 2.34)   2.37\*\*\* (2.14 to 2.63)
  UK and Ireland                                                                                    1.71\*\*\* (1.30 to 2.25)   1.88\*\*\* (1.45 to 2.45)   2.16\*\*\* (1.64 to 2.85)
  Northern Europe                                                                                   2.55\*\*\* (1.70 to 3.85)   2.27\*\*\* (1.59 to 3.23)   2.33\*\*\* (1.60 to 3.40)
  Southern Europe                                                                                   1.32 (0.94 to 1.84)         1.67\*\* (1.21 to 2.30)     2.07\*\*\* (1.45 to 2.95)
  Asia                                                                                              1.65^\#^ (0.99 to 2.76)     1.89\*\* (1.20 to 2.97)     1.63\* (1.02 to 2.61)

\*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001, ^\#^p=0.054.

BMI, body mass index; WC, waist circumference; WHR, waist-to-hip ratio.

[Table 4](#BMJOPEN2013004702TB4){ref-type="table"} summarises the results in [table 3](#BMJOPEN2013004702TB3){ref-type="table"} by presenting only statistically significant anthropometric obesity measures which increase the likelihood of individuals being above the treatment threshold, with measures of obesity ordered corresponding to ORs, from the highest to the lowest. WHR generally recorded higher ORs than WC and BMI and increased the likelihood of individuals of different ethnicity being above the respective treatment thresholds of the respective models. Only BMI presented higher ORs and increased the likelihood of Northern European women being indicated for treatment based on the predicted risk calculated from the general CVD model at the 10% threshold but not 20% threshold and Framingham model at the 20% threshold. WC recorded higher ORs in Asian women using the Framingham model at the 20% threshold.

###### 

Significant anthropometric measurements of general and central obesity and 10-year predicted risk of CVD incidence and mortality by ethnicity

  Ethnicity         General CVD (threshold=10%)   General CVD (threshold=20%)   Framingham (threshold=20%)
  ----------------- ----------------------------- ----------------------------- ----------------------------
  *OR criterion*                                                                
  Australia         WHR, WC, BMI                  WHR, WC, BMI                  WHR, WC, BMI
  UK and Ireland    WHR, WC, BMI                  WHR                           WHR, WC, BMI
  Northern Europe   BMI, WC, WHR                  WHR, WC, BMI                  BMI, WHR, WC
  Southern Europe   WHR, WC                       WHR                           WHR, WC
  Asia              --                            --                            WC, WHR, BMI\*

\*p=0.054.

Each cell represents statistically significant anthropometric measures of obesity ordered corresponding to ORs, from the highest to lowest.

BMI, body mass index; WC, waist circumference; WHR, waist-to-hip ratio.

Higher area under the ROC curve, sensitivity and specificity were recorded with WHR in predicting the 10-year CVD risk calculated using the general CVD and Framingham risk score models across most ethnic groups ([table 5](#BMJOPEN2013004702TB5){ref-type="table"}). The highest area under the ROC curve and specificity value at 80% sensitivity for WHR were 0.866 and 84.9% for Northern European women with the general CVD model at the 20% threshold.

###### 

Area under the curve and cut points for anthropometric measurements of general and central obesity to predict increased risk of CVD using risk score models at different thresholds for various levels of sensitivity and specificity by ethnicity

                                                                                       AUC                      Sensitivity=70%   Sensitivity=80%
  ------------------------------------------------------------------------------------ ------------------------ ----------------- -----------------
  *General CVD 10-year predicted risk for CVD incidence and death (threshold*=*10%)*                                              
  Australia                                                                                                                       
   BMI                                                                                 0.691 (0.666 to 0.716)   24.2 (60.1%)      23.0 (46.1%)
   WC                                                                                  0.750 (0.727 to 0.772)   77.3 (69.6%)      74.3 (57.9%)
   WHR                                                                                 0.759 (0.736 to 0.783)   0.77 (70.1%)      0.75 (58.0%)
  UK and Ireland                                                                                                                  
   BMI                                                                                 0.655 (0.584 to 0.726)   23.7 (50.6%)      22.8 (41.2%)
   WC                                                                                  0.676 (0.611 to 0.741)   75.3 (58.5%)      73.3 (51.2%)
   WHR                                                                                 0.729 (0.671 to 0.787)   0.77 (65.6%)      0.75 (52.4%)
  Northern Europe                                                                                                                 
   BMI                                                                                 0.770 (0.695 to 0.845)   25.8 (71.4%)      24.4 (58.7%)
   WC                                                                                  0.761 (0.682 to 0.840)   77.8 (66.7%)      75.3 (57.1%)
   WHR                                                                                 0.730 (0.642 to 0.817)   0.77 (59.5%)      0.75 (50.8%)
  Southern Europe                                                                                                                 
   BMI                                                                                 0.618 (0.536 to 0.699)   26.5 (52.8%)      25.5 (44.9%)
   WC                                                                                  0.686 (0.604 to 0.768)   81.8 (62.4%)      78.8 (53.4%)
   WHR                                                                                 0.702 (0.619 to 0.785)   0.80 (61.8%)      0.79 (57.9%)
  Asia                                                                                                                            
   BMI                                                                                 0.564 (0.411 to 0.717)   21.9 (38.2%)      21.8 (37.6%)
   WC                                                                                  0.651 (0.524 to 0.778)   73.3 (60.0%)      71.8 (52.4%)
   WHR                                                                                 0.614 (0.490 to 0.739)   0.76 (56.5%)      0.76 (54.7%)
  *General CVD 10-year predicted risk for CVD incidence and death (threshold*=*20%)*                                              
  Australia                                                                                                                       
   BMI                                                                                 0.725 (0.677 to 0.772)   25.5 (68.8%)      24.3 (58.1%)
   WC                                                                                  0.782 (0.743 to 0.821)   79.8 (72.3%)      77.8 (66.4%)
   WHR                                                                                 0.784 (0.745 to 0.823)   0.79 (76.3%)      0.77 (65.7%)
  UK and Ireland                                                                                                                  
   BMI                                                                                 0.550 (0.414 to 0.685)   23.0 (40.2%)      21.7 (25.4%)
   WC                                                                                  0.589 (0.472 to 0.706)   74.8 (52.2%)      73.8 (48.3%)
   WHR                                                                                 0.682 (0.572 to 0.791)   0.77 (61.3%)      0.75 (47.3%)
  Northern Europe                                                                                                                 
   BMI                                                                                 0.818 (0.727 to 0.908)   28.7 (82.4%)      26.3 (67.3%)
   WC                                                                                  0.861 (0.785 to 0.936)   85.3 (81.1%)      84.3 (79.2%)
   WHR                                                                                 0.866 (0.784 to 0.947)   0.84 (86.8%)      0.83 (84.9%)
  Southern Europe                                                                                                                 
   BMI                                                                                 0.578 (0.437 to 0.719)   26.8 (51.9%)      26.7 (50.9%)
   WC                                                                                  0.711 (0.562 to 0.859)   84.8 (69.6%)      84.8 (69.6%)
   WHR                                                                                 0.725 (0.553 to 0.897)   0.80 (62.1%)      0.79 (55.6%)
  Asia                                                                                                                            
   BMI                                                                                 0.555 (0.303 to 0.807)   25.4 (73.1%)      21.9 (37.9%)
   WC                                                                                  0.630 (0.466 to 0.795)   78.3 (73.6%)      71.8 (50.5%)
   WHR                                                                                 0.440 (0.306 to 0.573)   0.76 (52.2%)      0.74 (35.7%)
  *Framingham 10-year predicted risk for CVD incidence (threshold*=*20%)*                                                         
  Australia                                                                                                                       
   BMI                                                                                 0.682 (0.657 to 0.707)   24.0 (57.9%)      22.9 (43.8%)
   WC                                                                                  0.745 (0.723 to 0.768)   76.8 (67.5%)      73.8 (55.8%)
   WHR                                                                                 0.759 (0.736 to 0.781)   0.77 (69.7%)      0.75 (58.1%)
  UK and Ireland                                                                                                                  
   BMI                                                                                 0.656 (0.586 to 0.726)   23.7 (50.6%)      22.5 (37.5%)
   WC                                                                                  0.682 (0.620 to 0.745)   75.3 (58.6%)      73.3 (51.8%)
   WHR                                                                                 0.735 (0.679 to 0.791)   0.77 (65.8%)      0.75 (54.2%)
  Northern Europe                                                                                                                 
   BMI                                                                                 0.783 (0.710 to 0.856)   26.3 (75.2%)      24.9 (65.1%)
   WC                                                                                  0.770 (0.691 to 0.850)   78.8 (71.3%)      76.3 (60.5%)
   WHR                                                                                 0.742 (0.652 to 0.832)   0.77 (62.8%)      0.75 (51.2%)
  Southern Europe                                                                                                                 
   BMI                                                                                 0.597 (0.514 to 0.680)   25.8 (47.1%)      25.1 (40.1%)
   WC                                                                                  0.680 (0.601 to 0.760)   80.8 (57.6%)      78.3 (53.5%)
   WHR                                                                                 0.711 (0.633 to 0.789)   0.79 (61.6%)      0.78 (51.7%)
  Asia                                                                                                                            
   BMI                                                                                 0.647 (0.524 to 0.770)   23.5 (55.1%)      21.9 (39.5%)
   WC                                                                                  0.688 (0.586 to 0.790)   73.3 (60.5%)      71.8 (53.3%)
   WHR                                                                                 0.645 (0.530 to 0.759)   0.76 (56.9%)      0.75 (44.3%)

AUC, area under the curve; BMI, body mass index; WC, waist circumference; WHR, waist-to-hip ratio.

In Northern European women, BMI was a better predictor of CVD risk calculated using the general CVD risk score model at the 10% threshold but not 20% threshold and the Framingham risk score model at the 20% threshold, compared with WC and WHR. WHR, however, was the better indicator of CVD risk using the general CVD risk score model with a 20% threshold in Northern European women. In Asian women, WC reported a consistently higher area under the ROC curve, sensitivity and specificity across all CVD models and thresholds. The area under the ROC curve values ranged from 0.630 to 0.688 and specificity values ranged from 50.5% to 53.3% at 80% sensitivity in Asian women. The cut-off values for BMI, WC and WHR are also presented in [table 5](#BMJOPEN2013004702TB5){ref-type="table"}. A WHR value of 0.75 would indicate increased CVD risk for women from Australia and the UK and Ireland, while a value of 0.78 would indicate increased risk for Southern European women. In Asian women, a WC of 71.8 cm would indicate increased CVD risk. A BMI of 24.4 kg/m^2^ would indicate increased risk in Northern European women. The diagnostic abilities of the various anthropometric obesity measures to identify women as being above the threshold and hence identified for treatment vary according to ethnic groups.

Discussion {#s4}
==========

Our study found anthropometric measures of central obesity (WC and WHR) to be better indicators of CVD risk as they measure ectopic body fat (fat stored in the abdominal region), which is associated with decreased glucose tolerance, reduced insulin sensitivity, adverse lipid profiles and other metabolic abnormalities, which are risk factors for CVD and diabetes.[@R8] Stronger associations were also reported between WC and the 10-year predicted CVD risk calculated using the general CVD and Framingham risk score models compared with BMI and WHR across most ethnic groups, while WHR recorded higher ORs than WC and BMI and increased the likelihood of women being above the respective treatment thresholds of the models. WHR also presented higher area under the ROC curve, sensitivity and specificity values. Our findings are consistent with previous studies which have shown that WC and WHR, measures of central adiposity, are superior to BMI in predicting CVD and other obesity-related risk.[@R23] WC has already been incorporated in the diagnosis of the metabolic syndrome, a cluster of risk factors for CVD and diabetes.[@R27]

WHR should also be incorporated into CVD risk assessment. Our study provided evidence that WHR is a better diagnostic predictor of CVD than BMI and WC. It is also suitable for assessing adiposity and CVD risk in multiethnic cohorts as it has low measurement error, high precision and no bias over a wide range of ethnic groups.[@R13] Equivalence tests across ethnic groups showed WHR to be independent of ethnicity.[@R13] Similar cut-off values for WHR could also be applied across ethnic groups; a value of 0.75 and 0.78 would indicate increased CVD risk for women of Australia and UK and Ireland, and of Southern Europe descent, respectively. A study conducted on Latin Americans, non-Hispanic Whites and Blacks and Hispanics to estimate the accuracy and optimal cut points for BMI, WC and WHR also found that a cut point of 0.91 for WHR and 94 cm for WC could be used among women of different ethnicity to identify those at high coronary heart disease (CHD) risk.[@R28] WHR also reported the highest area under the ROC curve across all ethnic groups, ranging from 0.75 to 0.82.[@R28] It was also the most accurate measure to screen for high CHD risk individuals.[@R28] Another large case--control study of markers of obesity and myocardial infarction confirmed that WHR is a stronger indicator of myocardial infarction than BMI and increased the population attributable risk of obesity by more than threefold in all ethnic groups.[@R29] The superiority of WHR over BMI and WC in predicting CVD risk is also demonstrated in prospective studies.[@R23] [@R30]

The measurement of WHR, however, may pose some challenges. For example, it may be inappropriate to measure HC in certain cultures, but this can be overcome with same sex observers.[@R13] Some studies reported that WHR is imprecise while others reported that it is a precise measure.[@R13] [@R30] [@R34] [@R35] The differing results could be related to the rigour of the techniques used; standardised techniques need to be adopted when measuring WHR.[@R13] A study which evaluated the precision of measuring WHR, WC and HC with comparison across ethnic groups using data from the third Risk Factor Prevalence Study found that the coefficients of variation were 0.91% for WHR, 0.78% for WC and 0.57% for HC, less than 1%, indicating good precision in females.[@R13] The measurement error was 0.02 for WHR, 1.66 cm for WC and 1.59 cm for HC between two successive measurements in females.[@R13] In addition, the absolute difference between two WHR measurements for females was not significantly associated with the size of the participants.[@R13] WHR is not suitable for assessing central adiposity in the elderly[@R36] due to laxity of their abdominal muscles, which would undermine the predictive value of abdominal circumferences.[@R37] In addition, WHR may remain constant during weight change and is not suitable for monitoring weight loss.[@R38] Finally, there are technical difficulties in accurately measuring the HC of severely obese individuals (BMI≥40 kg/m^2^).[@R13] Measurements may be made in the supine position to overcome this problem.[@R13] In clinical settings, it may be more feasible to assess adiposity using WC while WHR could be measured in research studies as it is more informative.[@R30]

Although WHR was the best anthropometric obesity measure in relation to identifying individuals at increased CVD risk, this did not apply to Northern European women. BMI was a better indicator of CVD risk using the general CVD risk score model at the 10% threshold but not 20% threshold and the Framingham risk score model at the 20% threshold, with higher correlations, higher ORs, higher area under the ROC curves, sensitivity and specificity values presented, compared with WHR. At the 20% threshold of the general CVD risk score model, WHR was the better predictor of CVD risk in Northern European women compared to BMI. This indicates that the predictive ability of anthropometric measures of obesity varies with the treatment thresholds used for the respective risk score models, and that the same cut point may not be suitable across ethnic groups.

WC was a better predictor of CVD risk among Asian women compared to BMI and WHR. This was consistent with the results of another cross-sectional population-based survey study on Chinese people which reported that WC is the best predictor of CVD risk factors in women.[@R39] It was also the best marker of risk in a 6-year prospective study.[@R40] A small increment in WC predicted a substantial increase in CHD risk in the Chinese population.[@R40] It has been suggested that ethnicity influences specific fat depots, possibly explaining the relationship between ethnicity, adiposity and CVD risk.[@R41] A lower WC cut-off for Asians is necessary to avoid underestimating the population at risk.[@R41] [@R42]

Our study has limitations. It is a cross-sectional study of the Australian female population in 1989 and these results require confirmation from prospective studies. In addition, it is limited by the use of country of birth as a proxy for ethnicity.[@R43] Although country of birth is a good proxy for ethnicity in older age minority groups and is of intrinsic interest in distinguishing environmental and genetic differences, it is no longer an appropriate proxy as it does not consider the diversity of country of origin of the individual. The measurement or assignment of ethnicity is difficult and the way forward is possibly to enable people to identify themselves.[@R44] Owing to a sample size of about 200 for the Asian population, different regions in Asia could not be compared. Menopausal status, which is associated with increased central obesity, has not been assessed in our study and has not been incorporated into these risk score models.[@R45] Further, the CVD risk was estimated using risk score models in order to stratify individuals above and below the respective treatment thresholds and not actual CVD events. Only the Framingham and general CVD risk score models were assessed in our study. Other risk score models were excluded either because they could not be determined due to the requirement for variables not being assessed in our study (QRISK)[@R46] or due to the low number of participants above the respective recommended treatment thresholds (SCORE).[@R47] Finally, the 10-year CVD risk for young adults is very rarely elevated, even in the presence of significant risk factors.[@R48]

Conclusions {#s5}
===========

Our study confirms that ethnicity influences the association between anthropometric obesity measures and CVD risk. Central obesity measures such as WC and WHR are better indicators of CVD risk compared to BMI across ethnic groups. WHR is the best anthropometric measure for predicting CVD risk in women except Northern European and Asian women. The treatment threshold used for a risk score model affects the predictive ability of anthropometric obesity measures and the same cut point may not be suitable across ethnic groups.

It is important to incorporate ethnicity in CVD risk assessment. Prevention and treatment efforts should be tailored to meet the needs of each ethnic group.[@R49] Ethnic-specific CVD prevention strategies need to be developed to promote healthy eating and physical activity to curtail obesity. Continued population-based prospective research is necessary to elucidate the link between obesity and CVD by ethnicity.
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